Myeloma Minute
October 25, 2012
|
|
|
10.25.12 |
 |  |  |  | | October 25, 2012 |  |  |  |  |  |  | | |
 | |  | | Pomalidomide News: Promising Results Increase Chances of Early Drug Approval |  | | The results of a study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone have been released by Celgene International. This Phase III, multicenter, randomized, open label trial indicates that the pomalidomide arm of the study shows both improved progression free survival (PFS) and overall survival (OS). READ MORE | |
| | Should Myeloma Patients Get a Flu Shot? If So, Which One and When? |  | | The flu vaccine is safe for myeloma patients, and the IMF recommends that all myeloma patients receive a flu shot annually. Special considerations exist for stem cell transplant patients, those over 65, and those wondering if they might benefit from the “high-dose flu vaccine.” READ MORE | |
| | The IMF at 22: How Far We’ve Come! How Far We Still Have To Go! |  | | A lawn chair, an old coffee table, an IBM typewriter, a ream of paper, and three people with very different backgrounds: that was the checklist of assets and experience that the International Myeloma Foundation had when it was born 22 years ago, writes IMF President and Co-founder Susie Novis in her blog. “Every day, no matter our triumphs or tragedies, I usually have a moment reflecting on where we began.” READ MORE | |
| | IMF Nurse Leadership Board Member Recognized as 2012 Nurse of the Year |  |
| Congratulations to IMF Nurse Leadership Board member Joseph D. Tariman, Ph.D., of the Northwestern University Myeloma Program, on receiving a 2012 Nurse of the Year award from the Leukemia Research Foundation (LRF). The award was created to recognize hematology-oncology nurses who give their time, compassion, and heart each and every day. “These nurses are true heroes,” said Linda Kabot, LRF Director of Programs and Research Grants Administrator. | | | | | | | | Join Our Mailing List |
| | | |
| |
|
=
|
 related videos  related articles |
ASCO 2012: Dr. Pashos - Race- and health-related quality of life among patients newly diagnosed with multiple myeloma
10 PASSI PER CURA MIGLIORE®
10 Steps to Better Care®
10 Steps to Stress Control – From Fear to Hope
10 Steps to Happy Holidays
2011 IMF Holiday Gift Boutique
New Study: The Search for Criteria to Diagnose Active Myeloma at an Early Stage
Comprender El Tratamiento con Dosis Altas con Rescate de Células Madre
Advocacy Update - April 2013
Advocacy Update - March 2013
Advocacy Update - September 2012
Advocacy Update: The Healthcare Landscape in the Aftermath of the 2012 Elections
As the Bill Turns...Episode 3
ASCO 2012: Dr. Pashos - Race- and health-related quality of life among patients newly diagnosed with multiple myeloma
Audio Recording of Consensus on Care: Management of Side Effects of Novel Therapies Teleconference
Breaking News: Pomalyst® (pomalidomide) Approved by the FDA for Relapsed Myeloma
FDA Recognition of Extended Survival with VELCADE® Indicates Important New Progress in Treating the Disease
IMF 6th Annual Comedy Celebration
benefiting the Peter Boyle Research Fund
October 27, 2012
IMF Board Member Edith Mitchell, M.D., FACP, Named 2012 Recipient Of ASCO Humanitarian Award
IMF Nurse Leadership Board (NLB) White Paper on Subcutaneous Velcade® (bortezomib)
IMF Responds to Proposed Changes in CMS PET Scan Policy
It is Officially Myeloma Awareness Month Across the Country!
Live from ASH 2012: Journalists’ Workshop with Leading Myeloma Experts
Live! The Boca Raton Patient & Family Seminar
Living Well with Myeloma Teleconference Series:
How to Prevent Infection in Myeloma Patients
Myelom Merkur - Frühjahr 2012 - #901
MYELOMA AWARENESS MONTH 2012 FACT-A-DAY
Myeloma Canada Announces Recipient of this Year’s Research Grant
Myeloma Minute
April 11, 2013
Myeloma Minute
April 18, 2013
Myeloma Minute
April 26, 2012
Myeloma Minute
February 7, 2013
Myeloma Minute
January 31, 2013
Myeloma Minute
July 26, 2012
Myeloma Minute
June 28, 2012
Myeloma Minute
March 7, 2013
Myeloma Minute
May 17, 2012
Myeloma Minute
November 8, 2012
Myeloma Minute
May 24, 2012
Myeloma Today Spring 2013
New! Free Teleconference: Myeloma Updates 2012
Post ASCO/EHA/IMWG Summit
Pomalidomide + carfilzomib trial recruiting patients.
Should Myeloma Patients Get a Flu Shot? If So, Which One?
Special Myeloma Minute on FDA Approved Data for VELCADE®, including long-term survival data
STEP 7: CONSOLIDATION AND MAINTENANCE - ARE THEY NEEDED? REFERENCES
STEP 8: KEEPING TRACK OF THE MYELOMA - MONITORING WITHOUT MYSTERY
Stillwater, Minn., Myeloma Support Group Marks "Centennial" Anniversary
Teleconference: Myeloma Updates 2012
Post ASCO/EHA/IMWG Summit
The Emerging Role of Kyprolis in the Treatment Paradigm
The IMF Spearheads New Coalition’s First Meeting on State Health Exchanges
The Importance of Clinical Trial Participation - A teleconference with Dr. Brian G. M. Durie
September 8,2011
UPCOMING WEBCAST OF THE IMWG CONFERENCE SERIES "MAKING SENSE OF TREATMENT"
Wednesday, June 12, 2013 in Stockhom, Sweden
Клиническое значение электрофореза белковых фракций
step 1: get the correct diagnosis
publications
back
print